Trhová kapitalizácia spoločnosti OncoSec Medical Inc
Aká je hodnota metriky Trhová kapitalizácia spoločnosti OncoSec Medical Inc?
Hodnota metriky Trhová kapitalizácia spoločnosti OncoSec Medical Inc je $5.17M
Aká je definícia metriky Trhová kapitalizácia?
Trhová kapitalizácia (Market cap) je trhová hodnota vydaných akcií obchodovanej spoločnosti a je rovná cene akcie v danom čase vynásobenej počtom kusov vydaných akcií.
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Trhová kapitalizácia spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou OncoSec Medical Inc
Čomu sa venuje spoločnosť OncoSec Medical Inc?
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
Firmy s metrikou trhová kapitalizácia podobnou spoločnosti OncoSec Medical Inc
- Hodnota metriky Trhová kapitalizácia spoločnosti Bioasis Technologies je $5.15M
- Hodnota metriky Trhová kapitalizácia spoločnosti Stroud Resources je $5.15M
- Hodnota metriky Trhová kapitalizácia spoločnosti Cassius Mining je $5.15M
- Hodnota metriky Trhová kapitalizácia spoločnosti SEL Manufacturing je $5.16M
- Hodnota metriky Trhová kapitalizácia spoločnosti Dominate je $5.16M
- Hodnota metriky Trhová kapitalizácia spoločnosti Madhav Marbles and Granites je $5.16M
- Hodnota metriky Trhová kapitalizácia spoločnosti OncoSec Medical Inc je $5.17M
- Hodnota metriky Trhová kapitalizácia spoločnosti HangKan je $5.17M
- Hodnota metriky Trhová kapitalizácia spoločnosti Ascent Resources plc je $5.17M
- Hodnota metriky Trhová kapitalizácia spoločnosti Novatech Industries je $5.17M
- Hodnota metriky Trhová kapitalizácia spoločnosti Silver Chef je $5.18M
- Hodnota metriky Trhová kapitalizácia spoločnosti ManifestSeven je $5.18M
- Hodnota metriky Trhová kapitalizácia spoločnosti Zenlabs Ethica je $5.19M